Evidence supporting the use of: African Snakeroot
For the health condition: Schizophrenia

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Traditional
Rating (out of 5): 3

African Snakeroot (Rauvolfia vomitoria) has a longstanding history of use in traditional African medicine for a variety of conditions, including mental health disorders such as psychosis and schizophrenia-like symptoms. Its use in these contexts is primarily based on traditional knowledge and empirical observations rather than robust clinical evidence. The plant contains alkaloids such as reserpine, which is chemically similar to the active compound in Rauvolfia serpentina, an Indian species historically used for similar purposes. Reserpine was one of the earliest antipsychotic drugs introduced in Western medicine in the 1950s, and it works by depleting monoamines (such as dopamine) in the brain, thereby producing antipsychotic effects. However, most scientific studies and clinical trials have focused on Rauvolfia serpentina, not the African species. While R. vomitoria contains similar alkaloids, direct scientific evidence for its efficacy and safety in schizophrenia is limited. Some laboratory and animal studies suggest neuroactive properties, but controlled clinical data in humans is lacking. Potential side effects, including severe depression, cardiovascular effects, and extrapyramidal symptoms, have led to a decline in the use of reserpine-containing preparations. In summary, the use of African Snakeroot for schizophrenia is rooted in traditional medicine and informed by some pharmacological similarities to better-studied species, but strong scientific validation is currently lacking.

More about African Snakeroot
More about Schizophrenia

Products containing African Snakeroot

We currently have no products on Vitabase that contain this ingredient.